Barry Cohen

Title: Barry Cohen: Innovator in Influenza Vaccine Development

Introduction

Barry Cohen is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of immunology, particularly in the development of vaccines against influenza. His innovative work has led to the creation of a unique patent that addresses critical challenges in vaccine formulation.

Latest Patents

Cohen holds a patent for "Compositions of multimeric-multiepitope influenza polypeptides and their production." This patent focuses on pharmaceutical suspensions of multimeric-multiepitope influenza polypeptides, detailing processes for their production and their use as immunizing subjects against influenza. In particular, it discloses stable aqueous microparticulate suspensions of a multimeric multiepitope polypeptide, which are crucial for effective vaccine development.

Career Highlights

Barry Cohen has dedicated his career to advancing vaccine technology. His work at Biondvax Pharmaceuticals Ltd. has positioned him as a key player in the pharmaceutical industry. His innovative approaches have the potential to enhance the efficacy and stability of influenza vaccines, contributing to public health.

Collaborations

Cohen collaborates with talented professionals in his field, including Ram Uritski and Zohar Gadri. These partnerships foster a collaborative environment that drives innovation and research in vaccine development.

Conclusion

Barry Cohen's contributions to influenza vaccine development through his patent and work at Biondvax Pharmaceuticals Ltd. highlight his role as a significant inventor in the field. His innovative approaches are paving the way for more effective immunization strategies against influenza.